FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093066 [Registered on: 14/08/2025] Trial Registered Prospectively
Last Modified On: 12/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   To assess how effective Natrum muriaticum is in treating depressive disorder, measured by the 17-item Hamilton Depression Rating Scale. 
Scientific Title of Study   A prospective study on the effectiveness of natrum muriaticum in managing depressive disorder assesses using hamilton depression rating sacle-17 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vishnu Priya 
Designation  PG 
Affiliation  Sarada krishna homoeopathic medical college 
Address  Room number 513 4th floor no Department of psychiatry Sarada krishna homoeopathic medical college kulasekharam kanniyakumari Tamil nadu 629161
Kulasekharam
Kanniyakumari
TAMIL NADU
629161
India 
Phone  8825946342  
Fax    
Email  vp8413363@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P R Subi 
Designation  Professor 
Affiliation  Sarada krishna homoeopathic medical college 
Address  Room number 513 4th floor Department of pschyiatry Sarada krishna homoeopathic medical college kulasekharam kanniyakumari Tamil nadu 629161
Kulasekharam
Kanniyakumari
TAMIL NADU
629 161
India 
Phone  09486863644  
Fax    
Email  drsubinair@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr P R Subi 
Designation  Professor 
Affiliation  Sarada krishna homoeopathic medical college 
Address  Room number 513 4th floor Department of pschyiatry Sarada krishna homoeopathic medical college kulasekharam kanniyakumari Tamil nadu 629161
Kulasekharam
Kanniyakumari
TAMIL NADU
629 161
India 
Phone  09486863644  
Fax    
Email  drsubinair@gmail.com  
 
Source of Monetary or Material Support  
Institution- Sarada krishna homoeopathic medical college, kulasekharam kanniyakumari Tamil nadu 629161 
 
Primary Sponsor  
Name  Post graduated research funded by sarada krishna homoeopathic medical college 
Address  Sarada krishna homoeopathic medical college Kulasekharam kanniyakumari tamilnadu 629161 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vishnu priya K  Sarada krishna homoeopathic medical college  Room number 513 4th floor Department of psychiatry Sarada krishna homoeopathic medical college kulasekharam kanniyakumari
Kanniyakumari
TAMIL NADU 
9486863644

drsubinair@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F32||Major depressive disorder, singleepisode,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Natrum muriaticum  It is a commonly used remedy derived from ordinary table salt (NaCl), which is also called sodium chloride or common salt. This remedy has been tested and studied by homoeopathic pioneers such as Dr. Hahnemann, Dr. W.H. Schussler, and the Austrian Society of Provers. It is considered a "polychrest" remedy, meaning it can treat a wide range of symptoms. Natrum Muriaticum is known for its deep-acting and long-lasting effects.  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients diagnosed with depressive disorder according to ICD-10 criteria.
Age group - 18 to 65 years.
Both genders 
 
ExclusionCriteria 
Details  Patients with severe mental illness, currently on antidepressants or other
homoeopathic medicines.
Pregnant and lactation women
Patients under other psychiatric medications. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessment is done for every 2 weeks medication and the cases is followed up period
of 6 months 
6months 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment is done for every 2 weeks medication and the cases is followed up period
of 6 months 
6 months 
 
Target Sample Size   Total Sample Size="34"
Sample Size from India="34" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   30/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
INTRODUCTION: Depressive disorder is one of the most prevalent mental health conditions worldwide, characterized by persistent sadness, loss of interest, and impaired daily functioning. According to the World Health Organization (WHO), depression is a leading cause of disability globally, significantly impacting individuals’ quality of life, productivity, and overall well-being.  Natrum muriaticum is frequently prescribed based on the principle of individualization, especially in cases presenting with classical depressive symptoms like grief, sadness, and emotional suppression. The Hamilton Depression Rating Scale - 17 (HAM-D-17) is a validated and widely used clinician-administered questionnaire that assesses the severity of depression. It provides a structured method to
objectively evaluate the effectiveness of interventions aimed at reducing depressive symptoms. PROCEDURE: Patients diagnosed with depressive disorder, as per the ICD-10 criteria, will be assessed using the HAM-D-17 scale. After detailed case taking, Natrum muriaticum will be prescribed based on symptom similarity. At each follow-up visit, the assessment will be repeated using the HAM-D-17 scale. OUTCOME : The effectiveness of Natrum muriaticum will be assessed based on improvement in the Depressive Disorder HAM-D - 17 Scale.
 
Close